title: Chemiluminescence response of polymorphonuclear leucocytes to serum-opsonized zymosan--a predictive parameter for infections and prognosis in multiple myeloma patients.
abstract: Serum opsonization capability and phagocytosis by polymorphonuclear leucocytes (PMNL) were investigated in 37 patients with multiple myeloma (MM), 32 patients with chronic lymphocytic leukaemia (CLL), and 30 healthy controls. Opsonophagocytosis was assessed by measuring the chemiluminescence (CL) response of controls' and patients' PMNL to control- and patient-serum-opsonized zymosan particles. Control PMNL CL responses were significantly reduced both by MM and CLL sera. Normal sera restored the CL responses in MM patients, but only partially corrected the CL responses in CLL patients. Significant correlations were found between the CL responses in MM patients and four clinical parameters: clinical stage, presence of disease-related symptoms, incidence of bacterial infections, and outcome. The findings suggest a defect in MM and CLL sera opsonization ability which, at least in part, could account for the increased susceptibility to infections observed in these patients. Furthermore, the assessment of the CL response in MM patients is recommended as a simple and useful clinical tool for prediction of susceptibility to infection, and prognosis.
authors.affiliation: Department of Haematology, Rambam Medical Center, Haifa, Israel.
authors.forename: A
authors.initials: A
authors.lastname: Nagler
authors.forename: N
authors.initials: N
authors.lastname: Obedeanu
authors.forename: I
authors.initials: I
authors.lastname: Tatarsky
authors.forename: I
authors.initials: I
authors.lastname: Hocherman
authors.forename: D
authors.initials: D
authors.lastname: Merzbach
authors.forename: A
authors.initials: A
authors.lastname: Carter
mesh_terms: D000166:Acridines; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001424:Bacterial Infections / Q000276:immunology*; D004198:Disease Susceptibility; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000276:immunology*; D008163:Luminescent Measurements; D008165:Luminol; D008875:Middle Aged; D009101:Multiple Myeloma / Q000276:immunology*; D009504:Neutrophils / Q000276:immunology*; D009195:Peroxidase / Q000097:blood; D010587:Phagocytosis; D013481:Superoxides / Q000097:blood; D015054:Zymosan / Q000494:pharmacology
chemical_list: D000166:Acridines; D013481:Superoxides; C033472:10,10'-dimethyl-9,9'-biacridinium; D008165:Luminol; D015054:Zymosan; D009195:Peroxidase